Rhomboidal Pt(II) metallacycle-based NIR-II theranostic nanoprobe for tumor diagnosis and image-guided therapy

  • Yue Sun
    Key Laboratory of Pesticides and Chemical Biology, Ministry of Education, College of Chemistry, Central China Normal University, 430079 Wuhan, China;
  • Feng Ding
    Key Laboratory of Pesticides and Chemical Biology, Ministry of Education, College of Chemistry, Central China Normal University, 430079 Wuhan, China;
  • Zhixuan Zhou
    Department of Chemistry, University of Utah, Salt Lake City, UT 84112;
  • Chonglu Li
    Key Laboratory of Pesticides and Chemical Biology, Ministry of Education, College of Chemistry, Central China Normal University, 430079 Wuhan, China;
  • Maoping Pu
    Institute of Organic Chemistry, Rheinisch-Westfälische Technische Hochschule Aachen University, 52074 Aachen, Germany;
  • Yuling Xu
    Key Laboratory of Pesticides and Chemical Biology, Ministry of Education, College of Chemistry, Central China Normal University, 430079 Wuhan, China;
  • Yibei Zhan
    School of Chemistry and Chemical Engineering, Hubei Polytechnic University, Huangshi 435003, China
  • Xiaoju Lu
    School of Chemistry and Chemical Engineering, Hubei Polytechnic University, Huangshi 435003, China
  • Haibing Li
    Key Laboratory of Pesticides and Chemical Biology, Ministry of Education, College of Chemistry, Central China Normal University, 430079 Wuhan, China;
  • Guangfu Yang
    Key Laboratory of Pesticides and Chemical Biology, Ministry of Education, College of Chemistry, Central China Normal University, 430079 Wuhan, China;
  • Yao Sun
    Key Laboratory of Pesticides and Chemical Biology, Ministry of Education, College of Chemistry, Central China Normal University, 430079 Wuhan, China;
  • Peter J. Stang
    Department of Chemistry, University of Utah, Salt Lake City, UT 84112;

説明

<jats:title>Significance</jats:title> <jats:p>The biomedical applications of fluorescent anticancer agents in the first near-IR region (NIR-I) have been hampered by problems of photostability, autofluorescence, and limited penetration depth in biological tissues. To shift the fluorescence theranostic region from the NIR-I to the longer-wavelength region for accurate cancer diagnosis and treatment, Pt(II) metallacycle-based fluorescent nanoprobe 1 with fluorescence emission in the NIR-II region is designed. In vitro and in vivo studies demonstrate that 1 has good photostability and the ability to efficiently inhibit the growth of tumor with minimal side effects. It also improves the fluorescent imaging quality and signal-to-noise ratio for cancer theranostics. This study provides an opportunity for further design of NIR-II theranostic anticancer agents for future biomedical applications.</jats:p>

収録刊行物

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ